ResearchAarkstore Enterprise Molecular Diagnostics in Infectious Disease Testing

1
ResearchAarkstore Enterprise Molecular
Diagnostics in Infectious Disease Testing

• Aarkstore announce a new report   Molecular
  Diagnostics in Infectious Disease Testing 
• through its vast collection of market
  research report.

2
. - yStats.com delivers all research results as
PowerPoint files. All data can therefore be used
directly for board presentations or be
individually adapted. - If required, yStats.com
provides in-depth analysis for all research
projects. Simply send us a request. 4.) About
yStats.com yStats.com has been committed to
research up-to-date, objective and demand-based
data on markets and competitors for top managers
from various industries since 2005. Headquartered
in Hamburg, Germany, the firm has a strong
international focus and is specialized in
secondary market research. In addition to
offering reports on markets and competitors,
yStats.com also carries out client-specific
research. Clients include leading global
enterprises from various industries including B2C
E-Commerce, electronic payment systems, mail
order and direct marketing, logistics, as well as
banking and consulting. Table of Contents
1. MANAGEMENT SUMMARY 2. CENTRAL EUROPE 2.1.
Germany (Top Country)
http//www.aarkstore.com/search/viewresults.asp?s
earch2012PubIdpagenum1 http//www.aarkstore.c
om/search/viewresults.asp?searchMarketsPubIdpa
genum1 http//www.aarkstore.com/search/viewresult
s.asp?searchCancer20PubIdpagenum1 This
TriMark Publications report describes the
specific segment of the in vitro diagnostics
market known as molecular diagnostics testing for
infectious disease. In the current medical
diagnostics market, molecular diagnostics in
infectious disease testing offers one of the most
promising areas for growth and innovation. The
confluence of breakthroughs in genomics and
proteomics--along with the development of
microarray devices to measure analytes in the
blood--has led to this revolutionary market
development. Specifically, molecular diagnostics
offers the power of advanced analytical
techniques to diagnose infectious diseases.
Whereas before, the detection of many infectious
agents was slow and expensive due to reliance
upon culturing methods, researchers are now at
the cusp of overcoming such limitations via the
use of nucleic acid-mediated molecular
diagnostics testing. The purpose of this report
is to describe the emerging field of molecular
diagnostics in infectious disease testing. The
infectious disease space is the most dominant and
profitable sector of molecular diagnostics.
Topics covered in this study include 1) the
existing and emerging technologies in the field,
2) the U.S. and global market size for molecular
diagnostic products and 3) the profiles of
companies that are focusing on the molecular
diagnostic sector. The research examines drivers
and restraints for sales growth, market share and
technical trends. In addition, an in-depth
analysis of the competitive situation of
prominent market venders is provided with
five-year sales forecasts.   Table of Contents
1. Overview 141.1 Statement of Report 141.2
About This Report 151.3 Scope of the Report
151.4 Objectives 17
3
1.5 Methodology 171.6 Executive Summary 192.
Introduction to Molecular Diagnostics for
Infectious Disease Testing 272.1 Molecular
Diagnostics Testing and Opportunities in the
Infectious Disease Sector 272.2 The Infectious
Disease Problem 312.3 Impact of the Human Genome
Project on Molecular Diagnostics 352.4
Opportunities for Molecular and Clinical
Diagnostics 35 http//www.aarkstore.com/reports/
Molecular-Diagnostics-in-Infectious-Disease-Testin
g-91895.html   Neel Aarkstore Enterprise Phone081
49852585 Emailenquiry_at_aarkstore.com URLwww.aarks
tore.com http//www.facebook.com/aarkstoreenterpri
se http//in.linkedin.com/in/aarkstore
4
(No Transcript)
5
(No Transcript)